NCT04856332

Brief Summary

The intensive treatments of certain cancers and haemopathies require the implementation of a protective isolation from external micro-organisms for a period of several weeks. This isolation implies a limitation of visitors and sometimes prohibits access to young children. This raises questions concerning the maintenance of family links, and in particular the parent-child relationship as well as the psychological and emotional isolation of hospitalised patients and the resulting psychological effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2021

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 24, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 8, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2023

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

2.3 years

First QC Date

April 8, 2021

Last Update Submit

February 26, 2025

Conditions

Keywords

CancerLong-term protective isolationPatient-child relationship

Outcome Measures

Primary Outcomes (2)

  • Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation

    Observation of communications between the hospitalised patient and his/her chid(children) by a specialist in human and social sciences

    Through study completion, an average of 3 months

  • Evaluation of the use of a telepresence robot on the parent-child relationship in maintaining parenthood during parent's hospitalisation in long-term protective isolation

    Interview with the hospitalised patient (parent) by a specialist in human and social sciences

    Through study completion, an average of 3 months

Secondary Outcomes (5)

  • Evaluation of the experience linked to the robot availability on the concerned persons (patient, children, person on charge of children)

    Through study completion, an average of 3 months

  • Evaluation of patient's satisfaction

    Through study completion, an average of 3 months

  • Evaluation of the impact of robot use on patient's coping strategies (adaptation and adjustment to illness and hospitalisation)

    Through study completion, an average of 3 months

  • Evaluation of patient's experience of hospitalisation

    Through study completion, an average of 3 months

  • Evaluation of the impact of the robot's presence at home on the children and the person in charge of the children during patient's hospitalisation

    Through study completion, an average of 3 months

Interventions

Telepresence robot installed at child's home during parent's hospitalisation in long term protective isolation for maintaining parent-child ink (only children aged 15 years or less are concerned)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Observational prospective study, multicenter of parent-child relationship assessment following the setting up of a mobile telepresence robot for patients with children aged 15 years or less and hospitalised in long-term protective isolation. This study is based on semi-directed interviews and observations made during patient's hospitalisation and when patient returns at home.

You may qualify if:

  • Age≥ 18
  • Patient with at least one child aged 15 or under
  • Pathology requiring a prolonged hospitalization in protective isolation
  • Consent dated and signed

You may not qualify if:

  • Impaired cognitive functions
  • Performance Status -Eastern Cooperative Oncology Group (PS-ECOG) = 4
  • Difficulties in speaking and understanding French
  • Patient under guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centre Leon Berard

Lyon, 69008, France

Location

Centre Hospitalier Lyon Sud

Lyon, France

Location

Institut Paoli Calmettes

Marseille, 13000, France

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • GUILLERMIN Yann, MD

    Centre Leon Berard

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2021

First Posted

April 23, 2021

Study Start

February 24, 2021

Primary Completion

June 3, 2023

Study Completion

June 3, 2023

Last Updated

February 28, 2025

Record last verified: 2025-02

Locations